NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1336582659 D.O.
Verify on CMS → Matthew Crowe, D.O.
Pulmonary Disease Physician in Santa Fe, New Mexico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
722
Medicare Part D claims · 156 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
38%
generic claims · 62% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Matthew Crowe, D.O. filed 722 Medicare Part D claims in 2024 as a Pulmonary Disease Physician in Santa Fe, New Mexico, prescribing 38% generic.
- 722
- Part D claims, 2024
- 38%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥70th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Matthew Crowe, D.O.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1336582659), first enumerated 04/17/2013.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 722 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
4 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1336582659 · Pulmonary Disease Physician
NPI-10 · ENUM-MID · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1336582659
- ENUM-MID 2013
- TAX-MID 10K Pulmonary Disease
- RX-LIGHT 722
- BOOK-THIN 44 in New Mexico
- PHOTO-ENUM Katherine Gross · 2013
Matthew Crowe, D.O.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
722 ≥ 70th percentile 70% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Matthew Crowe, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 4 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Matthew Crowe, D.O.?
Quality data not reportedPrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
722 52% vs specialty avg
Specialty distribution in New Mexico
How Pulmonary Disease Physician compares to other specialties among New Mexico providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1336582659 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | D.O. |
| Gender | Male |
| NPI Issued | 04/17/2013 |
Hospital and facility affiliations
Facilities where Matthew Crowe, D.O. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Matthew Crowe, D.O. is affiliated with 4 Medicare-billing facilities across 4 states.
Nuvoair Medical PC
Dresden, TN
Privia Medical Group OF Georgia LLC
Fayetteville, GA
St Vincent Hospital
Santa Fe, NM
Tucson Physician Group Holdings LLC
Tucson, AZ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Brand-heavy
Matthew Crowe, D.O. - brand share 62.0%
Pulmonary Disease Physician average
62% brand-name claims vs 38% generic, on 722 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
722
Total Claims
$300K
Total Drug Cost
156
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 855.167
- Total Day Supply
- 22,442
- Brand vs Generic
- 62% brand / 38% generic
- Brand Drug Cost
- $294K
- Generic Drug Cost
- $6K
- Antibiotic Claims
- 63
Patient Demographics
- Average Patient Age
- 73.6 years
- Avg HCC Risk Score
- 1.89
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 17, 65-74: 67, 75-84: 60, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Matthew Crowe, D.O. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Albuterol Sulfate …
Albuterol Sulfate Hfa
128 claims
- Prednisone
Prednisone
73 claims
- Breztri Aerosphere
Breztri Aerosphere
54 claims
- Trelegy Ellipta
Trelegy Ellipta
54 claims
- Stiolto Respimat 49
Stiolto Respimat
49 claims
- Fluticasone-Salmet… 43
Fluticasone-Salmeterol
43 claims
- Breo Ellipta 38
Breo Ellipta
38 claims
- Azithromycin 35
Azithromycin
35 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 128 |
| Prednisone | 73 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 54 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 54 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 49 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 43 |
| Breo Ellipta Fluticasone/Vilanterol | 38 |
| Azithromycin | 35 |
| Spiriva Respimat Tiotropium Bromide | 31 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 25 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Matthew Crowe, D.O. fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Matthew Crowe, D.O.'s 722 claims are below the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Crowe, both outside New Mexico so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2013)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in New Mexico
Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as Crowe.
One of 44 Pulmonary Disease Physician providers enrolled in New Mexico, 5 are shown here.
Dr. Chidozie Agu
M.D.
Albuquerque, NM
Akshu Balwan
MBBS
Farmington, NM
Dr. Arnel Anthony Bobadilla
MD
Clovis, NM
Dr. Ronald Bronitsky
MD
Albuquerque, NM
Lee Brown
Albuquerque, NM
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Matthew Crowe, D.O.'s specialty? ▼
Matthew Crowe, D.O. specializes in Pulmonary Disease Physician and practices in Santa Fe, New Mexico. Credentials: D.O..
How much does Matthew Crowe, D.O. prescribe under Medicare Part D? ▼
In 2024, Matthew Crowe, D.O. wrote 722 Medicare Part D claims totaling $300K in drug costs for 156 beneficiaries.
Where is Matthew Crowe, D.O. located? ▼
Matthew Crowe, D.O. is located at 465 SAINT MICHAELS DR STE 117, Santa Fe, NM, 87505. Phone: (505) 984-2600.
What is Matthew Crowe, D.O.'s NPI number? ▼
Matthew Crowe, D.O.'s National Provider Identifier (NPI) is 1336582659, issued on 04/17/2013.
Does Matthew Crowe, D.O. prescribe more brand-name or generic drugs? ▼
Matthew Crowe, D.O.'s prescribing is 62% brand-name and 38% generic drugs by claim count, with $294K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Matthew Crowe, D.O. prescribe most often? ▼
Based on 2024 Medicare Part D data, Matthew Crowe, D.O.'s most frequently prescribed drugs include Albuterol Sulfate Hfa, Prednisone, Breztri Aerosphere. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matthew Crowe, D.O. accept Medicare? ▼
Matthew Crowe, D.O. appears in CMS Medicare data with 722 Part D claims and 156 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matthew Crowe, D.O.'s credentials? ▼
Matthew Crowe, D.O.'s NPI is 1336582659 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.